Cargando…

N(6)-methyladenosine methyltransferase KIAA1429 elevates colorectal cancer aerobic glycolysis via HK2-dependent manner

Emerging evidence has emphasized the critical roles played by N(6)-methyladenosine RNA (m(6)A) modification in colorectal carcinoma (CRC) initiation and progression. However, the roles and mechanism of m(6)A and KIAA1429 in CRC progression require further clarification. Here, our research aimed to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ying, He, Liang, Wang, Yingkai, Tan, Yan, Zhang, Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275915/
https://www.ncbi.nlm.nih.gov/pubmed/35546050
http://dx.doi.org/10.1080/21655979.2022.2065952
Descripción
Sumario:Emerging evidence has emphasized the critical roles played by N(6)-methyladenosine RNA (m(6)A) modification in colorectal carcinoma (CRC) initiation and progression. However, the roles and mechanism of m(6)A and KIAA1429 in CRC progression require further clarification. Here, our research aimed to investigate the functions of KIAA1429 in CRC tumorigenesis. Results indicated that KIAA1429 up-regulation closely correlated to the poor prognosis of CRC patients. Bio-functional assays demonstrated that KIAA1429 promoted the aerobic glycolysis, including glucose uptake, lactate production, ATP generation and extracellular acidification rate (ECAR). Mechanistically, KIAA1429 positively up-regulated HK2 level via increasing its mRNA stability by binding the m(6)A site of HK2 mRNA via m(6)A-independent manner. Collectively, our work indicates that KIAA1429 has the potential to promote CRC carcinogenesis by targeting HK2 via m(6)A-independent manner, providing insight into the critical roles of m(6)A in CRC.